drugset / Trial / NCT05054959

Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence

NCT05054959 ↗

Phase 2 Active not recruiting 62 enrolled Institute of Oncology Ljubljana
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to identify the most promising treatment sequence in total neoadjuvant therapy for locally advanced rectal cancer with a high risk of recurrence.

Timeline

Start
2021-06-24
Primary completion
2023-12-31
Completion
2028-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule 825 mg/m2 Oral
Subject Capecitabine Small molecule 1000 mg/m2 Oral
Subject Oxaliplatin Small molecule 130 mg/m2 Intravenous

Indications

No indication recorded.